
Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for…
Track top stocks like Tata Motors, IndusInd Bank, Kaynes Tech, and more as key updates and earnings could drive action…
Track key stocks like ITC, Tata Power, and MCX as their Q1 results and new deals drive trading action today…
Trump’s new tariffs spark uncertainty for India’s pharma exports and stocks; check out how the sector is reacting and what…
Stocks to watch today, July 31: GIFT Nifty indicates a lower start for domestic indices. Here are the top stocks…
Stocks to watch today, July 03: GIFT Nifty indicates a flat start for domestic indices. Here are the top stocks…
CuraTeQ Biologics, a wholly owned subsidiary of the company dedicated to oncology and immunology segments, has received authorisation from the…
Explore Goldman Sachs’ top 5 Indian pharma stock picks with up to 36% upside – see the full recommendations now!
Explore key stock moves today: major sales, profit jumps, and strategic deals heating up the market. Stay informed!
Aurobindo Pharma reported 10 per cent year-on-year dip in consolidated net profit at Rs 846 crore for the third quarter…
Pazopanib Tablets, 200 mg is indicated for the treatment of adults with Advanced Renal Cell Carcinoma (RCC), and Advanced Soft…
The company has has end-to-end capabilities in producing a full range of products from bulk drug substance to fill-finish and…
According to the company’s statement, this facility represents a strategic investment of ₹2,500 crores, under the Government of India’s PLI…
It is noteworthy that the company invested about Rs. 2,500 Crore to install a Penicillin-G manufacturing plant under the PLI…
Stocks to watch today: GIFT Nifty was up 22.50 points or 0.09% at 24,406 indicating a positive start for domestic…
Aurobindo Pharma reported a 13.3% increase in U.S. revenue year-on-year, reaching Rs 3,555 crore, which represents 47% of the company’s…
The injectable plant can produce 285 millions Vials/Ampoules annually and the Granulated products plant will produce 13,200 tonne annually, Aurobindo…
Aurobindo Pharma on Saturday reported a 41 per cent decline in its consolidated net profit at Rs 409 crore for…